Same Indication

Ipilimumab vs Pantoprazole

Ipilimumab vs Pantoprazole: Overview

This comparison examines the pharmacological differences between Ipilimumab and Pantoprazole.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pantoprazole: Proton pump inhibitor.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Pantoprazole — 1 hour.

Chemical Properties

Molecular Formula: Pantoprazole — C16H15F2N3O4S.

Molecular Weight: Pantoprazole — 383.3710 g/mol.

Type: Ipilimumab — Antibody; Pantoprazole — Small molecule.